Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph S Ross

Showing results (121-130 of 800) with videos related to

Pageof 80
Sort By:
JAMA Network Open|August 9, 2023
Transparency of Results Reporting in Cancer Clinical TrialsJennifer Kao, Joseph S Ross, Jennifer E Miller
The New England Journal of Medicine|December 14, 2016
The Rising Price of Naloxone - Risks to Efforts to Stem Overdose DeathsRavi Gupta, Nilay D Shah, Joseph S Ross
JAMA|August 21, 2024
Surrogate Markers and Clinical Outcomes-ReplyJoshua D Wallach, Reshma Ramachandran, Joseph S Ross
Journal of General Internal Medicine|July 10, 2024
Unveiling the Adoption and Barriers of Telemedicine in US Hospitals: A Comprehensive Analysis (2017-2022)John Xuefeng Jiang, Joseph S Ross, Ge Bai
Health Affairs Scholar|January 15, 2026
Changes in pharmaceutical industry payments to physicians after New Jersey's 2018 restrictionNeeraj G Patel, Reshma Ramachandran, Joseph S Ross
JAMA|November 12, 2021
Strengthening the FDA's Enforcement of ClinicalTrials.gov Reporting RequirementsReshma Ramachandran, Christopher J Morten, Joseph S Ross
Clinical Pharmacology and Therapeutics|November 25, 2018
Generic Drugs in the United States: Policies to Address Pricing and CompetitionRavi Gupta, Nilay D Shah, Joseph S Ross
Circulation. Cardiovascular Quality and Outcomes|March 23, 2012
The importance of clinical trial data sharing: toward more open scienceJoseph S Ross, Richard Lehman, Cary P Gross
JAMA Internal Medicine|February 13, 2023
US Food and Drug Administration Approval of Drugs Not Meeting Pivotal Trial Primary End Points, 2018-2021James L Johnston, Joseph S Ross, Reshma Ramachandran
JAMA Cardiology|November 3, 2016
Data Desert for Inferior Vena Caval Filters: Limited Evidence, Supervision, and ResearchBehnood Bikdeli, Joseph S Ross, Harlan M Krumholz
Pageof 80

Showing results (121-130 of 800) with videos related to

Sort By:
Pageof 80
JAMA Network Open|August 9, 2023
Transparency of Results Reporting in Cancer Clinical TrialsJennifer Kao, Joseph S Ross, Jennifer E Miller
The New England Journal of Medicine|December 14, 2016
The Rising Price of Naloxone - Risks to Efforts to Stem Overdose DeathsRavi Gupta, Nilay D Shah, Joseph S Ross
JAMA|August 21, 2024
Surrogate Markers and Clinical Outcomes-ReplyJoshua D Wallach, Reshma Ramachandran, Joseph S Ross
Journal of General Internal Medicine|July 10, 2024
Unveiling the Adoption and Barriers of Telemedicine in US Hospitals: A Comprehensive Analysis (2017-2022)John Xuefeng Jiang, Joseph S Ross, Ge Bai
Health Affairs Scholar|January 15, 2026
Changes in pharmaceutical industry payments to physicians after New Jersey's 2018 restrictionNeeraj G Patel, Reshma Ramachandran, Joseph S Ross
JAMA|November 12, 2021
Strengthening the FDA's Enforcement of ClinicalTrials.gov Reporting RequirementsReshma Ramachandran, Christopher J Morten, Joseph S Ross
Clinical Pharmacology and Therapeutics|November 25, 2018
Generic Drugs in the United States: Policies to Address Pricing and CompetitionRavi Gupta, Nilay D Shah, Joseph S Ross
Circulation. Cardiovascular Quality and Outcomes|March 23, 2012
The importance of clinical trial data sharing: toward more open scienceJoseph S Ross, Richard Lehman, Cary P Gross
JAMA Internal Medicine|February 13, 2023
US Food and Drug Administration Approval of Drugs Not Meeting Pivotal Trial Primary End Points, 2018-2021James L Johnston, Joseph S Ross, Reshma Ramachandran
JAMA Cardiology|November 3, 2016
Data Desert for Inferior Vena Caval Filters: Limited Evidence, Supervision, and ResearchBehnood Bikdeli, Joseph S Ross, Harlan M Krumholz
Pageof 80